Blood pressure control and left ventricular mass in children with chronic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 3, 2011, Pages 543-551

  Sinha, Manish D ^a   Tibby, Shane M ^a   Rasmussen, Pernille ^a   Rawlins, Debbie ^a   Turner, Charles ^b   Dalton, R Neil ^b   Reid, Christopher J D ^a   Rigden, Susan P A ^a   Booth, Caroline J ^a   Simpson, John M ^a  

^a EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; PHOSPHATE BINDING AGENT;

ADOLESCENT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CALCIUM INTAKE; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; GLOMERULUS FILTRATION RATE; HEART INDEX; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE MASS INDEX; HUMAN; MALE; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM; CHI-SQUARE DISTRIBUTION; CHILD; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY DISEASES; LINEAR MODELS; LONDON; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 79953023117     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04690510     Document Type: Article

References (35)

1. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH: Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25: 1056-1062, 1995
2. Turnbull F; Blood Pressure Lowering Treatment Trialists' Collaboration: Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials. Lancet 362: 1527-1535, 2003
3. McDonald SP, Craig JC: Long-term survival of children with end-stage renal disease. N Engl J Med 350: 2654-2662, 2004
4. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PW, Wright JT Jr: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 32: 853-906, 1998
5. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134: 629-636, 2001
6. Ravera M, Re M, Deferrari L, Vettoretti S, Deferrari G: Importance of blood pressure control in chronic kidney disease. J Am Soc Nephrol 17: S98-S103, 2006
7. Schaefer F: Cardiac disease in children with mild-to-moderate chronic kidney disease. Curr Opin Nephrol Hypertens 17: 292-297, 2008
8. Matteucci MC, Wuhl E, Picca S, Mastrostefano A, Rinelli G, Romano C, Rizzoni G, Mehls O, de Simone G, Schaefer F; ESCAPE Trial Group. Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol 17: 218-226, 2006
9. The ESCAPE Trial Group, Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Alfonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Möller K, Wigger M, Peruzzi L, Mehls O, Schaefer F: Strict blood pressure control and progression of renal failure in children. N Engl J Med 361: 1639-1650, 2009
10. Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, Kimball T, Furth S, Warady B; for the CKiD Study Group. Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol 21: 137-144, 2010
11. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr: Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC7 Report. JAMA 289: 2560-2572, 2003
12. 2003 European Society of Hypertension-European Society of Cardiology Guidelines for the management of arterial hypertension. J Hypertens 21: 1011-1053, 2003
13. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A: A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58: 259-263, 1976
14. Hogg RJ, Furth S, Lemley KV: National kidney foundation's kidney disease outcomes quality initiative clinical practice guidelines for chronic kidney disease in children and adolescents: Evaluation, classification, and stratification. Pediatrics 11: 1416-1421, 2003
15. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents: The Fourth Report on the Diagnosis, Evaluation and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 114: 555-576, 2004
16. Wuhl E, Witte K, Soergel M, Mehls O, Schaefer F, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R, Krull F, Reichert H, Reusz GS, Rascher W; German Working Group on Pediatric Hypertension: Distribution of 24-h ambulatory blood pressure in children: Normalised reference values and role of body dimensions. J Hypertens 20: 1995-2007, 2002
17. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ: Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Qualification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18: 1440-1463, 2005
18. Simpson JM, Savis A, Rawlins D, Qureshi S, Sinha MD: Incidence of left ventricular hypertrophy in children with kidney disease: Impact of method of indexation of left ventricular mass. Eur J Echocard 11: 271-277, 2010
19. Khoury PR, Misnefes M, Daniels SR, Kimball TR: Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr 22: 709-714, 2009
20. Foster BJ, Mackie AS, Mitsnefes M, Ali H, Mamber S, Colan SD: A novel method of expressing left ventricular mass relative to body size in children. Circulation 117: 2769-2775, 2008
21. de Simone G, Daniels SR, Kimball TR, Roman MJ, Romano C, Chinali M, Galderisi M, Devereux RB: Evaluation of concentric left ventricular geometry in humans: Evidence for age-related systematic underestimation. Hypertension 45: 64-68, 2005
22. Vickery S, Stevens PE, Dalton RN, van Lente F, Lamb EJ: Does the ID-MS traceable MDRD equation work and is it suitable for use with compensated Jaffe and enzymatic creatinine assays? Nephrol Dial Transplant 21: 2439-2445, 2006
23. C Booth, C Turner, RN Dalton. Estimated glomerular filtration rate (eGFR) in children [Abstract]. Pediatr Nephrol 22: 1543, 534(P), 2007
24. Levin A, Singer J, Thompson CR, Ross H, Lewis M: Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 27: 347-354, 1996
25. Rijnbeek PR, van Herpen G, Kapusta L, Ten Harkel AD, Witsenburg M, Kors JA: Electrocardiographic criteria for left ventricular hypertrophy in children. Pediatr Cardiol 29: 923-928, 2008
26. Daniels SR, Kimball TR, Morrison JA, Khoury P, Meyer RA: Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol 76: 699-701, 1995
27. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH: Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20: 1251-1260, 1992
28. Sluysmans T, Colan SD: Theoretical and empirical derivation of cardiovascular allometric relationships in children. J Appl Physiol 99: 445-457, 2005
29. Goldsmith D, Ritz E, Covic A: Vascular calcification: A stiff challenge for the nephrologist - Does preventing bone disease cause arterial disease? Kidney Int 66: 1315-1333, 2004
30. Lilien MR, Groothoff JW: Cardiovascular disease in children with CKD or ESRD. Nat Rev Nephrol 5: 229-235, 2009
31. Litwin M, Wuhl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Troger J, Mehls O, Schaefer F: Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 16: 1494-1500, 2005
32. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342: 1478-1483, 2000
33. Briese S, Wiesner S, Will JC, Lembcke A, Opgen-Rhein B, Nissel R, Wernecke KD, Andreae J, Haffner D, Querfeld U: Arterial and cardiac disease in young adults with childhoodonset end-stage renal disease impact of calcium and vitamin D therapy. Nephrol Dial Transplant 21: 1906-1914, 2006
34. Lewis MA, Shaw J, Sinha MD, Adalat S, Hussain F, Castledine C, Schalkwyk DV, Inward C. UK Renal Registry 12th Annual Report (December 2009): Chapter 14 Demography of the UK paediatric renal replacement therapy population in 2008. Nephron Clin Pract 115[Suppl 1]: c279-c288, 2010
35. Lurbe E, Cifkova R, Cruickshank JK, Dillon MJ, Ferreira I, Invitti C, Kuznetsova T, Laurent S, Mancia G, Morales-Olivas F, Rascher W, Redon J, Schaefer F, Seeman T, Stergiou G, Wühl E, Zanchetti A; European Society of Hypertension: Management of high blood pressure in children and adolescents: Recommendations of the European Society of Hypertension. J Hypertens 27: 1719-1742, 2009